Prostate Cancer Androgen Deprivation Medication Savings with TheDrugClub
Discount pricing may be available. Current formulary eligibility is being verified; a condition association does not establish FREE coverage.
- Join TheDrugClub for $19.95/month
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
Prostate Cancer Androgen Deprivation Medications, Costs & Savings
Pharmacist insight
Medication adherence is particularly critical for oral chemotherapy agents. I work closely with patients to manage side effects that might cause them to skip doses. Many supportive care medications — anti-nausea drugs, growth factors — are available in generic form, helping reduce the overall cost burden of cancer treatment.
Angela C. Beverly, PharmD
About Prostate Cancer Androgen Deprivation
Prostate cancer often relies on male hormones for growth. Androgen Deprivation Therapy (ADT) is a critical treatment designed to block these hormones, slowing disease progression. While life-saving, the cost of ADT medications can be substantial. TheDrugClub is dedicated to helping members afford these vital prescriptions, ensuring access to necessary care without overwhelming financial stress.
Prostate cancer is one of the most common cancers among men, and its progression is often fueled by male hormones, primarily testosterone. Androgen Deprivation Therapy (ADT), also known as hormone therapy, is a cornerstone treatment for many men with prostate cancer. The goal of ADT is to reduce the levels of male hormones in the body or to block their effects on prostate cancer cells, thereby slowing the cancer's growth and spread.
What is Androgen Deprivation Therapy?
ADT works by targeting the androgens (male hormones) that act as fuel for prostate cancer cells. By lowering androgen levels or preventing them from reaching cancer cells, ADT can shrink tumors, slow disease progression, and manage symptoms. It's often used for advanced prostate cancer, cancer that has recurred after initial treatment, or sometimes in conjunction with radiation therapy for high-risk localized cancer.
Common Treatments and Medications
Several types of medications are used in ADT, each working through different mechanisms:
- Luteinizing Hormone-Releasing Hormone (LHRH) Agonists: These drugs, such as leuprolide (Lupron, Eligard), goserelin (Zoladex), and triptorelin (Trelstar), cause a temporary surge in testosterone followed by a sustained drop to very low levels. They are often given as injections every few weeks or months.
- LHRH Antagonists: Medications like degarelix (Firmagon) or relugolix (Orgovyx) directly block the production of testosterone without the initial hormone surge seen with agonists.
- Antiandrogens: Drugs like bicalutamide (Casodex), flutamide, and nilutamide block the androgen receptors on prostate cancer cells, preventing androgens from stimulating growth. They are often used in combination with LHRH agonists.
- Newer Androgen-Targeting Drugs: These include abiraterone (Zytiga), enzalutamide (Xtandi), apal
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.